GHK-Cu (Glycine-Histidine-Lysine Copper) is one of the most well-characterized peptides in skin biology and tissue repair research. First isolated from human plasma in 1973 by Dr. Loren Pickart, this naturally occurring copper peptide complex has been the subject of hundreds of preclinical studies examining its role in collagen synthesis, wound healing, antioxidant defense, and gene regulation — making it an indispensable tool in dermal and connective tissue research.
What Is GHK-Cu?
GHK-Cu is a tripeptide (Gly-His-Lys) complexed with a copper (II) ion. It is naturally present in human plasma, saliva, and urine, and its plasma concentrations decline significantly with age — from approximately 200 ng/mL at age 20 to under 80 ng/mL by age 60. This age-related decline has made GHK-Cu a subject of intense interest in aging and regenerative biology research.
Key Areas of In Vitro Research
Collagen and Extracellular Matrix Synthesis
GHK-Cu is one of the most studied peptides for its effects on collagen production. In vitro studies using fibroblast cell lines have demonstrated that GHK-Cu stimulates the synthesis of collagen types I, III, and IV, as well as elastin and glycosaminoglycans. Research has also shown its ability to upregulate matrix metalloproteinases (MMPs) while simultaneously stimulating TIMP (tissue inhibitor of metalloproteinase) expression, suggesting a role in balanced extracellular matrix remodeling.
Antioxidant Gene Upregulation
One of the most striking findings in GHK-Cu research is its broad effect on gene expression. Microarray studies have shown that GHK-Cu can modulate the expression of over 4,000 human genes, with significant upregulation of antioxidant defense genes including superoxide dismutase (SOD), catalase, and glutathione S-transferase. In vitro research has explored these gene expression changes in multiple cell line models, positioning GHK-Cu as a powerful tool for studying oxidative stress biology.
Wound Healing and Cell Migration
In vitro scratch assay studies have demonstrated that GHK-Cu significantly accelerates keratinocyte and fibroblast migration, key processes in wound closure. Research has also examined its ability to stimulate nerve outgrowth and blood vessel formation in cell culture models, suggesting multi-tissue applications in regenerative biology research.
TGF-β Signaling Modulation
GHK-Cu has been investigated for its interaction with TGF-β (transforming growth factor beta) signaling pathways. In vitro research has shown that GHK-Cu can modulate TGF-β isoform expression in fibroblast models, with implications for understanding scar formation, fibrosis, and tissue remodeling at the molecular level.
GHK-Cu in Multi-Peptide Research Blends
For researchers interested in studying synergistic peptide interactions, GHK-Cu is also available as a component of the GLOW blend (BPC-157 10mg + GHK-Cu 50mg + TB4 10mg) — a proprietary triple-peptide research formulation designed for comprehensive in vitro studies of skin biology and tissue repair pathways.
GHK-Cu at Everlast Research
Everlast Research supplies GHK-Cu as a high-purity (≥98% HPLC verified) lyophilized powder in 50mg quantities, providing researchers with a generous supply for extended experimental protocols and dose-response studies.
Research Compliance Note
All GHK-Cu products from Everlast Research are strictly for in vitro laboratory research use only. Not for human or veterinary use. Use only in certified laboratory environments under proper compliance.
Everlast Research supplies high-purity lyophilized research compounds for qualified laboratory professionals. All products are for in vitro research use only.